These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7853209)

  • 1. Protective effects of AE0047, a novel calcium antagonist, on incidence of stroke and hemodynamic disturbances in stroke-prone spontaneously hypertensive rats.
    Shinyama H; Nagai H; Kawamura T; Narita Y; Uchida T; Watanabe M; Kagitani Y
    J Pharmacol Exp Ther; 1995 Feb; 272(2):911-9. PubMed ID: 7853209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 4th communication: prophylactic and therapeutic effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3- b]pyridine-5-carboxylate in stroke-prone spontaneously hypertensive rats.
    Ueda M; Masui M; Kawakami M; Matsunaga K; Gemba T; Ninomiya M; Nakano A; Torii M; Adachi I; Ito H
    Arzneimittelforschung; 1993 Dec; 43(12):1291-303. PubMed ID: 8141816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic effects of a new 1,5-benzothiazepine calcium antagonist on stroke in salt-loaded stroke-prone spontaneously hypertensive rats.
    Kikkawa K; Murata S; Iwasaki H; Toriumi W; Banno K; Nagao T
    Arzneimittelforschung; 1992 Jun; 42(6):781-6. PubMed ID: 1418031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of MPC-1304, a novel calcium antagonist, on stroke-prone spontaneously hypertensive rats.
    Niwa M; Shigematsu K; Maeda T; Fujimoto M; Yamashita K; Kataoka Y; Taniyama K
    Arch Int Pharmacodyn Ther; 1994; 327(3):309-29. PubMed ID: 7848014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a novel calcium antagonist, S-(+)-methyl-4,7-dihydro-3-isobutyl-6- methyl-4-(3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate (S-312-d), on ischemic amino acid release and neuronal injury in stroke-prone spontaneously hypertensive rats.
    Gemba T; Ninomiya M; Matsunaga K; Ueda M
    J Pharmacol Exp Ther; 1993 Apr; 265(1):463-7. PubMed ID: 8474028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of AE0047, a novel calcium antagonist, on progression of brain damage after stroke in stroke-prone spontaneously hypertensive rats.
    Shinyama H; Nagai H; Kawamura T; Narita Y; Nakamura N; Kagitani Y
    Gen Pharmacol; 1998 Mar; 30(3):379-86. PubMed ID: 9510090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
    Kanda A; Haruno A; Miyake H; Nagasaka M
    J Cardiovasc Pharmacol; 1992; 20(5):723-30. PubMed ID: 1280733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective action of lacidipine in cardiac hypertrophy of the spontaneously hypertensive stroke-prone rat: an ultrastructural study.
    Cristofori P; Sbarbati A; Accordini C; Terron A; Micheli D
    J Submicrosc Cytol Pathol; 1994 Jul; 26(3):331-40. PubMed ID: 8087797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive effect of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride in rats.
    Wada K; Nakamura S; Morishita S; Kanda M; Matsui H; Fukata F; Shirahase H
    Arzneimittelforschung; 1994 Oct; 44(10):1112-6. PubMed ID: 7818582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benidipine, an anti-hypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats.
    Matsubara M; Akizuki O; Ikeda J; Saeki K; Yao K; Sasaki K
    Eur J Pharmacol; 2008 Feb; 580(1-2):201-13. PubMed ID: 18048030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azelnidipine decreases sympathetic nerve activity via antioxidant effect in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats.
    Konno S; Hirooka Y; Araki S; Koga Y; Kishi T; Sunagawa K
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):555-60. PubMed ID: 19057394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of stroke with perindopril treatment in stroke-prone spontaneously hypertensive rats.
    Wang H; Delaney KH; Kwiecien JM; Smeda JS; Lee RM
    Clin Invest Med; 1997 Oct; 20(5):327-38. PubMed ID: 9336658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephroprotective effect of treatment with calcium channel blockers in spontaneously hypertensive rats.
    Sabbatini M; Vitaioli L; Baldoni E; Amenta F
    J Pharmacol Exp Ther; 2000 Sep; 294(3):948-54. PubMed ID: 10945845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium antagonists in prevention of hypertension and stroke in stroke-prone spontaneously hypertensive rats.
    Liu LS; Zhao Y; Lei YP; Wang W; Zhang XE; Jin L
    Chin Med J (Engl); 1989 Feb; 102(2):106-13. PubMed ID: 2505975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the calcium antagonist AE0047 on the development of neurological deficit and infarction after middle cerebral artery occlusion in stroke-prone spontaneously hypertensive rats.
    Shinyama H; Kawamura T; Iwamoto M; Egi Y; Tanaka H; Kawabata Y; Nakamura N; Kagitani Y
    J Pharm Pharmacol; 1997 Sep; 49(9):919-24. PubMed ID: 9306262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional vascular effects of MPC-1304, a novel dihydropyridine derivative, in conscious normotensive and spontaneously hypertensive rats.
    Miyoshi K; Kanda A; Nozawa Y; Nakano M; Miyake H
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1328-36. PubMed ID: 8667194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antihypertensive effects of a novel calcium antagonist, AE0047, in various hypertensive models].
    Kido H; Nishikawa M; Hayashi K; Kubo Y; Ohtaki Y; Fujino Y; Egi Y; Ebisu H; Inoue S; Yamanaga K; Uchida T; Nakamura N
    Nihon Yakurigaku Zasshi; 1997 Jun; 109(6):279-89. PubMed ID: 9253775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats.
    Stier CT; Adler LA; Levine S; Chander PN
    J Hypertens Suppl; 1993 Apr; 11(3):S37-42. PubMed ID: 8315518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vasodilator effects of LF 2.0254, a new 1,4-dihydropyridine. Comparison with nifedipine].
    Pruneau D; Roy F; Brown NL
    Therapie; 1989; 44(3):203-8. PubMed ID: 2781506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.